Hansoh Pharmaceutical Group Company Ltd Financials

Market Capitalization HK$239.15 Billion as of Jan. 1, 2026

Valuations Metrics as of Jan. 3, 2026

Trailing PE	40.94
Forward PE	36.01
Price to Sales TTM	HK$16.43
Price to Book MRQ	HK$6.26
Enterprise to Revenue	14.38
Enterprise to EBITDA	39.41

Financial Reports as of Jun. 30, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-06-30
Profit Margin	36.25%
Operating Margin	42.42%
Return on Assets TTM	8.35%
Return on Equity TTM	16.21%

Income Statement

Revenue TTM	HK$14,665,762,100
Revenue per Share TTM	HK$2.22
Quarterly Revenue Growth	14.30%
Gross Profit TTM	HK$13,322,269,927
EBITDA	HK$6,061,756,589
Net Income to Common TTM	HK$5,316,631,085
Diluted EPS TTM	HK$0.89
Quarterly Earnings Growth YoY	15.00%

Balance Sheet

Total Cash MRQ	HK$30,158,281,081
Total Cash per Share MRQ	HK$4.56
Total Debt MRQ	HK$
Total Debt to Equity MRQ	0.38
Current Ratio MRQ	8.56
Book Value per Share MRQ	HK$5.82

Cash Flow

Operating Cash Flow TTM	HK$5,321,326,950
Levered Free Cash Flow TTM	HK$3,656,688,407

3692 Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding	5,945,955,423
Float Shares	1,208,039,763
Avg 10 Volume	4,509,449
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	79.67%
% Held by Institutions	9.27%

Stock Price Summary

Beta	0.61
Fifty Two Week Low	HK$15.96
Fifty Two Week High	HK$44.22
Fifty Two Week Change	54.50%
Day 50 MA	HK$38.37
Day 200 MA	HK$32.42

Dividends and Splits

Forward Annual Dividend Rate	HK$0.46
Forward Annual Dividend Yield	1.27%
Trailing Annual Dividend Rate	HK$0.37
Trailing Annual Dividend Yield	1.01%
Payout Ratio	38.12%
Dividend Date
Ex Dividend Date	2025-09-22
Last Split Factor
Last Split Date